Stock 399 INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Innovative Pharmaceutical Biotech Limited

Equities

399

BMG4783W1073

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-05-14 EDT 		5-day change 1st Jan Change
0.195 HKD +1.04% Intraday chart for Innovative Pharmaceutical Biotech Limited -2.50% -10.96%
2023 Innovative Pharmaceutical Biotech Returns to Fiscal H1 Attributable Profit MT
2023 Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Innovative Pharmaceutical Biotech Returns to Fiscal H1 Attributable Profit
MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2023
CI
Innovative Pharmaceutical Biotech to Return to Profit in Fiscal H1
MT
Innovative Pharmaceutical Biotech Limited Provides Unaudited Earnings Guidance for the Six Months Ended 30 September 2023
CI
Innovative Pharmaceutical Biotech Limited Announces Change of Address of Principal Place of Business in Hong Kong
CI
Innovative Pharmaceutical Eyes Majority Stake in US Neurotechnology Firm
MT
Innovative Pharmaceutical Biotech Limited entered into a memorandum of understanding to acquire a majority interest in Niraxx Light Therapeutics, Inc.
CI
Innovative Pharmaceutical Plans HK$55.5 Million Bond Issue
MT
Innovative Pharmaceutical to Raise HK$58 Million From Deal with US Firm Genuine Marketing
MT
Innovative Pharmaceutical Biotech Limited announced that it expects to receive HKD 55.5 million in funding
CI
Innovative Pharmaceutical Biotech Limited Appoints Cheng Tak Yiu as an Executive Director
CI
Innovative Pharmaceutical Biotech Incurs Loss in Fiscal Year 2023
MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Innovative Pharmaceutical Biotech Mulls Over Capital Injection in Technical Services Company
MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2022
CI
Innovative Pharmaceutical Biotech Forecasts Swing to Loss in April-September Period
MT
Innovative Pharmaceutical Biotech Limited Provides Group Earnings Guidance for the Six Months Ending 30 September 2022
CI
Innovative Pharmaceutical Biotech Limited Auditor Raises 'Going Concern' Doubt
CI
Innovative Pharmaceutical Biotech Limited Announces Delay in Publication of Audited Annual Results for the Year Ended 31 March 2022
CI
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 399 Stock
  4. News Innovative Pharmaceutical Biotech Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW